Abstract-Arterial lesions in cardiovascular diseases are characterized by proliferation and migration of smooth muscle cells as well as deposition of connective tissue matrix. Factors that stimulate vascular smooth muscle cell (VSMC) proliferation are well described; however, the role of proteins that limit intimal hyperplasia is not well understood.
A therosclerotic plaques are complex lesions in which repair of tissue injury is associated with VSMC proliferation, connective tissue formation, and calcium deposition. 1 Mitogen-dependent stimulation of VSMC division has been described; however, the mechanisms by which cell proliferation is inhibited during vascular remodeling are not well understood. In many cells, transit through G 1 of the cell cycle and entry into the S phase require the binding and activation of cyclin/CDK complexes, predominantly cyclin D/Cdk4 or Cdk6 and cyclin E/Cdk2. 2, 3 The CKIs are naturally occurring gene products that inhibit cyclin/CDK activity and phosphorylation of Rb ϩ , resulting in G 1 arrest. 4, 5 CKIs directly implicated in CDK regulation are p21 Cip1 , 6 ,7 p27
Kip1 , 8 -10 and p16/p15
INK . 11 Since cell proliferation is a prominent feature of cardiovascular diseases, including atherosclerosis, angiogenesis, and restenosis, we hypothesized that CKIs regulate G 1 progression in VSMCs and function as endogenous inhibitors of VSMC proliferation.
Two families of CKIs have been identified: the Kip/Cip proteins (p21 Cip1 , p27 Kip1 , and p57 Kip2 ) and the INK proteins (p15  INKB , p16  INKA , p18  INKC , and p19  INKD ) . The Kip/Cip proteins contain a conserved domain that is necessary and sufficient for cyclin-CDK interaction and inhibition in proliferating cells. 12 In vitro experiments indicate that multiple molecules of Kip are required with a cyclin/CDK complex for inhibition of kinase activity. 13 Amino acids 17 to 71 of p21 Cip1 contain the cyclin/CDK binding and inactivation domain. 12 Similar homologous domains are present in p27 Kip1 with amino acids 26 to 88. 14, 15 We and others have found that p21 Cip1 is upregulated in arteries after vascular injury and that overexpression of p21 Cip1 in VSMCs results in G 1 arrest and inhibition of cell growth. 16, 17 There are several properties of p27 Kip1 suggesting that it might also have an important role regulating entry into and exit from the mitotic cycle. Ectopic expression of p27 Kip1 cDNA is sufficient to induce G 1 arrest, and there is a correlation between growth arrest and the amount of p27/Cdk2 complex under antimitogenic conditions. 14, 18 Given these properties of p27 Kip1 , we hypothesized that p27 Kip1 might be expressed in VSMCs and function to establish an inhibitory threshold that G 1 CDKs must surpass before activation and entry into the S phase. We speculated further that p27 would be upregulated in arterial tissues after vascular injury to inhibit VSMC proliferation and promote arterial repair. Finally, we sought to compare the expression and function of p27 Kip1 with an INK protein, p16
INK .
Materials and Methods

Cell Culture and Cell Cycle Analysis
Primary porcine aortic VSMCs were isolated by an explantation method 19 and maintained in medium 199 containing 20% FCS. Twenty-four hours before cell cycle analysis, VSMCs were carried in medium 199 with 0.2% BSA or medium 199 with 20% FCS. For analysis of the cell cycle distribution, cells were harvested 24 hours later, washed with PBS twice, fixed in 2% paraformaldehyde for 60 minutes, and permeabilized in 0.2% Tween 20. The cells were treated with 1 U of DNase-free RNase in 1 mL of PBS for 30 minutes at 37°C, resuspended in 0.03 mg/mL propidium iodide, and analyzed by flow cytometry using a FACScan model (Becton Dickinson).
Western Blot and Immunoprecipitation
Porcine aortic VSMCs were cultured in medium 199 with 20% FCS. Cell lysates were prepared as described. 16 Western blot analysis was performed on whole-cell lysates by incubating VSMCs in lysis buffer (50 mmol/L Tris, pH 7.5, 250 mmol/L NaCl, 2 mmol/L EDTA, 10% glycerol, and 0.1% NP-40) supplemented with protease and phosphatase inhibitors (0.5 mmol/L PMSF, 10 g/mL aprotinin, 10 g/mL leupeptin, 1 mmol/L NaF, 0.1 mmol/L Na 3 VO 4 , and 1 mmol/L DTT) on a rocking platform at 4°C for 30 minutes. Cellular debris was removed by centrifugation at 16 000g for 10 minutes, and protein concentration was determined by the Bradford assay. Eight micrograms of protein was loaded per lane, resolved by SDS-PAGE under reducing conditions, blotted on polyvinylidene fluoride membranes, and incubated with monoclonal antibodies to detect p27 (No. K25020, Transduction Laboratories) and p16 (No. 13251A, Pharmingen) with a horseradish peroxidase-coupled secondary antibody using SuperSignal (Pierce) as substrate.
Immunoprecipitations were performed by dilution of whole VSMC lysates in 1 mL of buffer (50 mmol/L Tris, pH 7.5, 150 mmol/L NaCl, 2 mmol/L EDTA, and 0.1% NP-40) supplemented with protease and phosphatase inhibitors (0.5 mmol/L PMSF, 10 g/mL aprotinin, 10 g/mL leupeptin, 1 mmol/L NaF, 0.1 mmol/L Na 3 VO 4 , and 1 mmol/L DTT). Diluted lysates were precleared with an isotype antibody and then incubated with the Cdk2 antibody for 3 hours on a rocking platform at 4°C. Immunoprecipitates were washed three times in 1 mL of buffer and then used for Western blot analysis or for kinase assays. For H1 kinase assays, immunoprecipitates were washed in 1 mL of kinase buffer (50 mmol/L Tris, pH 7.5, 10 mmol/L MgCl 2 , 20 mol/L ATP, 1 mmol/L NaF, 0.1 mmol/L Na 3 VO 4 , and 1 mmol/L DTT) and resuspended in 25 L of this buffer. The kinase reaction was performed for 30 minutes at 37°C in the presence of 10 Ci [␥ 32 -P]ATP (ICN) with 1 g histone H1 (Boehringer) as substrate. Labeled proteins were resolved on 15% SDS-PAGE and subjected to autoradiography.
Arterial Tissues
After anesthesia and intubation, domestic Yorkshire pigs (12 to 15 kg) underwent sterile surgical exposure of the femoral arteries in accordance with institutional animal care guidelines. A double-balloon catheter (C.R. Bard, Inc) was inserted into the femoral artery. The proximal balloon was inflated to a pressure of 500 mm Hg for 5 minutes. Animals were killed 1, 4, 7, 14, 21, and 60 days later (nϭ8 arteries at each time point). Normal, uninjured iliofemoral arteries (nϭ8) were also examined. The arteries were perfusion-fixed with 10% buffered formalin at physiological pressures (100 mm Hg), placed in 10% formalin for 4 hours, followed by 70% ethanol for 18 hours, and paraffin-embedded, and immunohistochemistry for p27
Kip1 and p16
INK was performed. Thirty-five specimens of aorta and coronary arteries were obtained from hearts removed from 25 patients (18 men and 7 women, ages 21 to 67) undergoing heart transplantation at the University of Michigan. Tissues were snap-frozen in liquid nitrogen for Western blot analysis and stored at Ϫ70°C or fixed in 10% buffered formalin for 4 hours, followed by 70% ethanol for 18 hours, and paraffin-embedded for immunohistochemistry. Sections (6 m thick) were placed onto poly-L-lysine-coated slides. Sections were stained with hematoxylin and eosin, and immunostaining for p27 Kip1 , p21 Cip1 , and p16 INK was performed.
The hematoxylin and eosin-stained sections were examined in a blinded manner by an experienced cardiovascular pathologist (D.G.) and were classified into three groups by classic histological criteria: diffuse intimal hyperplasia, characteristic of aging human arteries without clinical or morphologic evidence of atherosclerosis (nϭ8); early atherosclerosis, characterized by some lipid deposition and focal necrosis (nϭ7); and advanced atherosclerosis, with a fibrous cap, necrotic core, lipid deposition, and calcification (nϭ20). Immunostaining and analysis of CKI expression were performed after classification. A scoring system was established (D.G.) to mark the specimen with positive immunostaining. Positive staining was defined as expression of the respective CKI in the intima of the arterial lesion in Ͼ5% of the cells.
Immunohistochemistry
Immunohistochemistry was performed with the following primary antibodies: a mouse monoclonal anti-mouse p27 antibody, 1:100 dilution (No. 13231A, Pharmingen); a rabbit polyclonal anti-human p16 antibody, 1:5000 dilution (No. 759, Santa Cruz); a rabbit polyclonal anti-human p21 antibody, 1:500 dilution (No. 756, Santa Cruz); a mouse monoclonal anti-Ki67 antibody, 1:500 dilution (AMAC); a mouse monoclonal anti-smooth muscle ␣-actin antibody, 1:500 dilution (Boehringer-Mannheim); a mouse monoclonal antihuman CD68 antibody, 1:500 dilution (Dako); a monoclonal SP1.d8 aminopeptide-specific type I procollagen antibody, 1:500 dilution (Developmental Studies, Hybridoma Bank, University of Iowa); and an affinity-purified rabbit anti-human TGF-␤1 antibody.
20 Sections (6 m thick) were placed on poly-L-lysine-coated slides, deparaffinized in three changes of xylene, and rehydrated in 100%, 95%, and 75% ethanol. Slides were incubated in 0.3% hydrogen peroxide for 30 minutes to exhaust endogenous peroxidase activity. Primary antibodies were diluted in PBS with 1% BSA and applied to the slides for 12 hours at 4°C. After several washes in PBS, a biotinylated horse anti-mouse or horse anti-rabbit secondary antibody (1:400 dilution, Zymed) was applied for 30 minutes at room temperature, followed by an alkaline phosphatase reagent (Vector Labs) for 30 minutes at room temperature, yielding a red reaction product. Methyl green was used as a nuclear counterstain. Control experiments were performed using purified rabbit serum or a secondary antibody alone that did not stain the arterial specimens. The mouse monoclonal antibody was specific for pig p27 Kip1 , as determined by immunostaining of porcine artery sections with the anti-p27 antibody, which had been preabsorbed with whole-cell lysate from L293 cells transfected with p27 plasmid (pRcCMV-p27) or the control plasmid encoding ␤-galactosidase (RcCMV-lacZ). L293 cells were transfected with pRcCMV-p27, pRcCMV-p16, or pRcCMV-lacZ by the calcium phosphate method. The cells were washed in PBS 48 hours after transfection and
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Immunohistochemistry was also performed on formalin-fixed paraffin-embedded specimens with a mouse monoclonal anti-Ki67 antibody, 1:500 dilution (AMAC), using immunoperoxidase staining. Serial sections were placed onto poly-L-lysine-coated slides, deparaffinized in three changes of xylene, and rehydrated in 100%, 95%, and 75% ethanol. Slides were then blocked with 10% normal goat serum in PBS containing 1% BSA and incubated with the Ki67 antibody for 30 minutes at room temperature. A biotinylated horse anti-mouse secondary antibody was applied for 30 minutes, followed by an avidin-biotin-peroxidase conjugate (Vector Labs) for 30 minutes at room temperature. 3,3Ј-Diaminobenzidine with nickel chloride was added to yield a black reaction product, and methyl green was used as a nuclear counterstain. Double-label immunohistochemistry was performed using previously described methods 21 on formalin-fixed tissue using the following primary antibodies: a mouse monoclonal anti-mouse p27 antibody, 1:100 dilution (No. 13231A, Pharmingen); a rabbit polyclonal antihuman p21 antibody, 1:500 dilution (No. 756, Santa Cruz); a mouse monoclonal anti-smooth muscle ␣-actin antibody, 1:500 dilution (Boehringer-Mannheim); a mouse monoclonal anti-human CD68 antibody, 1:500 dilution (Dako); a monoclonal SP1.d8 aminopeptidespecific type I procollagen antibody, 1:500 dilution (Developmental Studies, Hybridoma Bank, University of Iowa); and a monoclonal mouse anti-BrdC antibody, 1:1000 dilution (Amersham Life Sciences).
To determine the percentage of intimal cells expressing procollagen, immunohistochemistry was performed with a procollagen antibody as described above. Total nuclei and procollagen-positive nuclei were counted in the intima of normal and injured arteries by a microscope-based video image analysis system (Image One Systems, Universal Imaging Corp). 19 Eight high-power fields were counted in four sections from each artery. A percentage of positive procollagen cells was calculated as the ratio of labeled cells to the total number of cells. The data for each artery were averaged, and a mean and standard error were calculated for eight arteries at each time point. The data are expressed as meanϮSEM. 
Results
CKI Expression in Arrested and Proliferating VSMCs
CKI expression in VSMCs was first analyzed in vitro in the absence or presence of serum. Cells incubated in media with 0.2% BSA for 24 hours displayed G 1 arrest (82% in G 1 ; Fig 1A,  left) and showed high levels of p27 Kip1 ( Fig 1B, lane 1) . After exposure to 20% FCS, proliferation resumed, with the proportion of G 1 cells decreasing substantially (44% in G 1 ; Fig 1A,  right) . At the same time, p27
Kip1 levels decreased to undetectable levels as determined by Western blot analysis (Fig 1B, lane  2) . Similarly, VSMCs synchronized in G 1 by culture in BSA for 72 hours displayed high levels of p27
Kip1 (Fig 1B, lane 3) , which declined to undetectable levels within 24 hours after addition of FCS (Fig 1B, lanes 4 to 9) . p21
Cip1 showed a similar trend (data not shown). p16
INK levels did not change in arrested compared with proliferating cells (Fig 1B, lanes 1 to 9) . Incubation of VSMCs in BSA for up to 72 hours did not lead to cell death as determined by the sub-G 1 peak of propidium iodide-stained cells (data not shown). Proliferation of VSMCs in response to serum resulted in decreased cellular p27 Kip1 ( Fig  1C, row 1) as well as Cdk2-associated p27 Kip1 ( Fig 1C, row 3) , whereas the cellular level of Cdk2 did not change under these conditions ( Fig 1C, row 2) . Accordingly, the Cdk2-associated H1 kinase activity was increased in the proliferating cells, indicating that the low p27
Kip1 levels in the presence of growth factors permitted proliferation to occur (Fig 1C, row 4) . Western blot analysis of p27
Kip1 and p16 INK expression in cultured VSMCs and in the arterial wall demonstrated that p27
Kip1 was present in both isolated cells and intact tissue, whereas p16
INK could be detected in the cultured cells only ( Fig  1C, rows 1 and 5 ). These studies suggest that p27
Kip1 , but not p16 INK , is induced in VSMCs in association with G 1 arrest in vitro and that this induction mediates cell cycle exit.
CKI Expression During Arterial Repair
Expression of CKI proteins was next characterized in porcine arteries, which are well studied as a model for human vascular disease. 22, 23 After balloon injury in this species, smooth muscle cell proliferation began in the intima within 1 to 2 days, peaked 7 days later with 15% to 18% of intimal cells undergoing proliferation, declined rapidly to Ͻ2% of intimal cells by day 14 (Fig 2J) , and remained at this low level at days 21 through 60. 19 In normal, uninjured arteries, p27
Kip1 expression was detected in the intima, media, and adventitia (Fig 2A) . After balloon injury to the artery, p27
Kip1 expression decreased by day 4 (Fig 2B) , and levels remained low through day 7 (Fig 2C) . After balloon injury, there was an acellular region in the mid-medial region and an absence of staining in this region. Expression of p27
Kip1 was observed in the developing neointima at day 14 ( Fig 2D) , and expression continued at day 21 (Fig 2E and  2F ) and day 60 (Fig 2G) . At these time points, p27 Kip1 expression was observed throughout the intima (Fig 2F) but in many sections was seen primarily in the lower regions of the intima, adjacent to the internal elastic lamina (Fig 2E) . p27
Kip1 expression persisted in the artery even at day 60, when the response to injury was complete (Fig 2G) .
To explore factors that might account for this pattern of p27
Kip1 expression in the intima, immunohistochemical studies were performed with antibodies to procollagen and TGF-␤. In the normal pig artery, Ϸ3% of cells in the intima and media were positive for procollagen, as might be expected for an artery not undergoing remodeling (Fig 3) . After balloon injury, Kip1 expression is present in normal, uninjured arteries (A). After balloon injury, p27
Kip1 protein expression declines in the intima and media (B, 4 days after injury; C, 7 days after injury). After 7 days, p27
Kip1 expression increases and is observed in the intima at 14 days (D), 21 days (E and F), and 60 days (G). Twenty-one days after injury, p27
Kip1 and procollagen are coexpressed by the intimal smooth muscle cells (H and I, see arrows; I, procollagen red stain and p27 brown stain). Low levels of proliferation are present at 21 days, shown by BrdC staining (J). Immunostaining for TGF-␤ demonstrates TGF-␤ expression in the same regions of the intima as p27 Kip1 
expression 21 days after injury (K, control antibody; L, TGF-␤ antibody). In contrast, p16 INK is not present in normal arteries (M), is expressed only transiently after arterial injury (N, 4 days), and is not detected after repair is completed (O and P, 21 and 60 days, respectively). Control studies were performed on 293 cells transfected with p27
Kip1 or p16 INK expression plasmid (ϩ) and 293 cells transfected with control plasmid (Ϫ). The black arrows indicates the internal elastic lamina. procollagen expression in the intima increased to 6.8Ϯ1.1% of cells at day 1 and remained at this approximate level until 7 days after injury (day 4, 6.3Ϯ2.1%; day 7, 7.2Ϯ2.6%). By 14 days, however, the percentage of positive procollagen cells in the intima increased further to 10.1Ϯ0.8% and to 14.3Ϯ1.4% at day 21. Procollagen immunostaining was observed throughout the intima (Fig 2H and 2I) . The percent positive procollagen cells at 60 days was 5.0Ϯ1.2%.
TGF-␤ expression was also present in the intima at 14 and 21 days after vascular injury. Two patterns of staining were observed. In some regions of the artery, TGF-␤ was present throughout the intima, whereas in other sections, expression was observed primarily in the lower regions of the intima, adjacent to the internal elastic lamina in a pattern similar to p27
Kip1 expression (Fig 2L) . This localization to the innermost regions of the intima was observed in previous studies of TGF-␤ overexpression in pig arteries after vascular gene transfer. 20 In previous studies, in contrast to p27 Kip1 , p21 Cip1 protein has not been detected in normal arteries; however, after injury, its levels were found to increase in the same region as p27 Kip1 when VSMC proliferation decreased. 16 Unlike p27 Kip1 , p21
Cip1 was undetectable by 60 days when the response to injury was complete. Interestingly, the pattern of p16 expression differed from p27 Kip1 and p21 Cip1 and was detected only transiently before the peak onset of cell proliferation (day 4) (Fig 2N) . This is consistent with the observation that p16 was not detectable in the uninjured artery by immunohistochemistry (Fig 2M) .
These data suggest that p27 Kip1 is normally expressed in VSMCs in pig arteries, downregulated after arterial injury, and upregulated in the intima when cell proliferation is decreasing and procollagen synthesis is present (Fig 4) .
CKI Expression During Atherogenesis
To determine whether CKI expression was abnormal in human cardiovascular disease, we examined expression patterns in 35 coronary artery segments from cardiac transplant recipients classified as normal with DIT (nϭ8 arteries), early atherosclerosis (nϭ7 arteries), or advanced atherosclerosis (nϭ20 arteries) (Table) . p27
Kip1 was expressed in intimal and medial VSMCs as well as in adventitial fibrocytes of nonatherosclerotic arteries (7 of 8 arteries) (Fig 5, top panel) . p21 Cip1 was detected only at low levels (1 of 8 arteries), was not expressed in the absence of p27 Kip1 , and was detected more prominently in the intima and media compared with the adventitia (Fig 5, top panel) . p21
Cip1 expression was often eccentric compared with p27
Kip1 expression, suggesting that its presence may reflect a response to arterial injury or stress. p16
INK was not detected in any artery with DIT (0 of 8 arteries).
In early atherosclerosis, p27 Kip1 and p21 Cip1 were present in similar regions of the intima and media (p27, 5 of 7 arteries; p21, 4 of 7 arteries), whereas p16
INK was not detected in any artery with early atherosclerosis (Fig 5,  middle panel) . In advanced atherosclerotic lesions, p27 Kip1 and p21
Cip1 were both detected within plaques, particularly in regions with the greatest accumulation of matrix and the least cellularity (p27, 20 of 20 arteries; p21, 15 of 20 arteries) (Fig 5, bottom panel) . Although p27
Kip1 was more abundant than p21
Cip1 in these lesions, the frequency of cells containing p21
Cip1 was markedly increased with the increasing severity of atherosclerosis (Fig 5, bottom panel) . A nearly 100-fold higher frequency was seen in advanced atherosclerosis compared with normal arteries or those with early atherosclerosis. In contrast, p16
INK was not observed in atherosclerotic lesions. Cell proliferation was measured in these specimens by immunostaining for the proliferation marker Ki67. 24 Cell proliferation indices in early and advanced atherosclerosis were low (Ͻ2% of plaque cells), similar to previously reported findings. 25 p27 Kip1 , p21 Cip1 , and p16
INK expression was not observed within plaque cells Cyclin-Dependent Kinase Inhibitors undergoing proliferation, and CKI expression was more commonly observed in regions of the plaque not undergoing proliferation.
Expression of CKIs in Human Atherosclerosis
To identify the cells expressing these CKIs, costaining with antibodies to smooth muscle ␣-actin and the macrophage marker CD68 was performed. The majority of cells expressing p27
Kip1 and p21 Cip1 in early and advanced atherosclerosis were VSMCs (Ϸ87%) (Fig 6A and 6B) , and the remainder were identified as macrophages (Fig 6E and 6F ) by double-labeling techniques. Expression of p27
Kip1 and p21 Cip1 was variable in lumenal endothelium of large arteries; however, there was abundant and uniform expression of p27 Kip1 and p21 Cip1 within plaque and adventitial microvessels in endothelium and smooth muscle cells (Fig 6C and  6D) . Western blot analyses performed on extracts from coronary arteries confirmed the presence of the expected size proteins in these tissues (data not shown).
Discussion
Vascular proliferative diseases, such as atherosclerosis and restenosis, are characterized by intimal smooth muscle cell growth in response to vascular injury. The signaling pathways by which VSMCs proliferate in response to mitogenic signals are well described (reviewed in References 26, 27, and others). However, the role of cellular gene products that cause VSMCs to shift from a proliferative state to a quiescent state during the G 1 phase of the cell cycle are not well understood. The purpose of the present study was to examine the expression of the CKIs p27 Kip1 , p21 Cip1 , and p16
INK in normal and diseased arterial tissue. We found that p27
Kip1 and p21 Cip1 are expressed in distinct temporal patterns in normal, injured, and diseased arteries in vivo. Kip1 , but not p21 Cip1 , is constitutively expressed in normal pig arteries. p27
Kip1 is downregulated after arterial injury when cell proliferation increases. p27
Kip1 is upregulated in later phases of arterial remodeling and is associated with a decline in cell proliferation and an increase in procollagen and TGF-␤ synthesis. Of interest, p16
INK was expressed only transiently in pig arteries after injury and was not observed in normal arteries or chronic lesions. In human lesions, p27
Kip1 was expressed in atherosclerotic and nonatherosclerotic lesions in cells not undergoing proliferation. p21 Cip1 expression increased as the severity of atherosclerotic lesions progressed and was not seen in the absence of p27 Kip1 28 who have demonstrated that Cip1 and p27 Kip1 and expression in microvessels. Atherosclerotic human coronary arteries were double-labeled with anti-p27 (A, C, and E) or anti-p21 (B, D, and F) antibodies and the smooth muscle cell marker ␣-actin (A, B, C, and D) or the macrophage marker CD68 (E and F).
Staining for p27
Kip1 or p21 Cip1 is indicated by the red staining; that for smooth muscle cell ␣-actin or CD68 is indicated by the blue reaction product. Cells with double labeling are indicated by the purple color (arrows). Methyl green is used as a nuclear counterstain. p27
Kip1 (A) and p21 Cip1 (B) expression in the intima and media colocalized with smooth muscle cells. Intraplaque microvessels showed strong and uniform expression of p27 Kip1 (C) and p21
Cip1 (D). Abundant macrophages (blue stain) within the plaque also expressed p27
Kip1 (E) and p21 Cip1 (F).
fibrillar collagen regulates early integrin signaling, which induces p27 Kip1 and p21 Cip1 expression in VSMCs and downregulates Cdk2 expression. In the present study, we found that p27
Kip1 and procollagen are expressed at low levels in the intima during the first 7 days after arterial injury. During this time period, smooth muscle cells are proliferating, and the neointima is forming. Between 7 and 14 days in this model, there is a decline in smooth muscle cell proliferation, an increase in p27
Kip1 and p21 Cip1 expression, and an increase in procollagen expression in the intima. There is also a correlation temporally and spatially between p27
Kip1 and TGF-␤ expression. These data suggest that there is an association between p27
Kip1 , procollagen, and TGF-␤ expression and an inverse correlation between these factors and cell proliferation. These observations lend support to the report by Koyama et al that specific signaling through integrin receptors could contribute to differential expression of p21 Cip1 and p27 Kip1 in arterial lesions. In addition to signals mediated by matrix attachment, growth stimulatory signals also decline during this period after injury. This may contribute to increased CKI levels, especially in the case of p27 Kip1 , as suggested by the serum starvation experiments with cultured VSMCs. The decline in p27
Kip1 expression during VSMC proliferation after arterial injury could also contribute to the increased Cdk2 activity. 29 We have previously reported that p21
Cip1 expression is also increased in injured arterial lesions after 7 days. Although these findings are similar to those currently reported for p27 Kip1 , there are distinct differences in expression patterns between p21
Cip1 and p27 Kip1 in injured pig arteries and human atherosclerosis. p27
Kip1 is constitutively expressed in normal arteries, whereas p21
Cip1 is not, and p27 Kip1 is found in all phases of atherosclerotic and nonatherosclerotic human coronary disease, whereas p21
Cip1 is observed in advanced atherosclerosis. These findings suggest that p27
Kip1 may function to maintain normal VSMCs in G 0 /G 1 and to inhibit cell proliferation during the latter phases of arterial repair. p21
Cip1 may function as a cofactor that is induced in the latter phases of arterial remodeling to inactivate CDK/cyclin complexes and cause G 1 arrest.
These studies in pig arteries and human lesions suggest that p27
Kip1 sets a balance between proliferating and nonproliferating cells in arteries. These findings support evidence from previous studies in p27 Kip1 knockout mice. Disruption of the CDK binding domain of the p27
Kip1 gene in mice enhances growth. 30 -32 Growth results from an increase in cell number, due to increased cell proliferation, which is most obvious in tissues that ordinarily express p27
Kip1 at the highest levels, such as thymus, pituitary, and ovaries. In the present study, we observed an inverse correlation between VSMC proliferation and p27
Kip1 expression, again suggesting a role for p27 Kip1 in setting a balance between proliferating and nonproliferating VSMCs. Although the gene disruption studies implicate p27 Kip1 function in development, the expression studies reported here demonstrate a major role for p27 Kip1 in repair and remodeling of arteries after vascular injury. As such, these studies lend support to the concept that CKIs regulate cell cycle progression in VSMCs and point to potential therapies for vascular proliferative diseases.
